Study of MEDI0382 in Combination With Dapagliflozin and Metformin in Overweight/Obese Participants With Type 2 Diabetes
Clinical trial NCT03444584 · COMPLETED
Trial details
- NCT number
- NCT03444584
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-08
- Primary completion
- 2018-12-06
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.